University of Thessaly (UTH)
Ψυχολογικές συνέπειες από την έλλειψη εμμήνου ρύσεως, λόγω της υπερπρολακτιναιμίας, σε γυναίκες 18-45 ετών, που πάσχουν από ψύχωση, και λαμβάνουν φαρμακευτική αγωγή με τυπικά ή άτυπα αντιψυχωσικά
Abstract
dc:descriptionIntroduction: Hyperprolactinemia comprises one of the most frequent consequences of antipsychotic medication and it can have many adverse clinical effects, like amenorrhea, that occurs to women of reproductive age, after being treated with typical and also many of the atypical antipsychotics. Objective: This study aims to investigate the psychological effects and the attitude towards menstruation of psychotic women who suffer from antipsychotic medication induced hyperprolactinaemia that leads to amenorrhea, related to hyperprolactinemic women who have not reported amenorrhea. Materials and Methods: Two hundred and sixty three (263) females, diagnosed with a psychotic disorder (DSM-IV-TR), 18-45 years old, were examined. The patients were under treatment with either risperidone or haloperidol or olanzapine or quetiapine. Blood- sampling was conducted, in order to measure the levels of prolactin in serum. The quantitative determination was made by Chemiluminescence Immuno Assay (CLIA). Then, two self- report psychometric instruments were distributed, the Symptom- Checklist – 90- R (SCL-90-R) questionnaire and the Menstrual Attitude Questionnaire (MAQ). All data were analyzed and the scales and subscales of the questionnaires were compared using the MANOVA model ( Multivariate Analysis of Variance).Results: 139 out of 263 women were found with hyperprolactinemia. Strong statistical signifi-cance arouse between hyperprolactinaemia and the four antipsychotic agents (p<0.0005). Women who developed high prolactin levels show severe psychopathology, like depression, paranoid ideation, anxiety, psychoticism and hostility (p<0.0005). In addition, they regard men-struation as a debilitating and bothersome effect, although it is considered to be a natural effect and an integral part of their life. Women with hyperprolactinemia cannot predict the onset of menstruation and they deny any effect of it on their bodies. 67 out of 139 hyperprolactinemic women manifested menstrual disturbances, primarily amenorrhea. Statistical significant difference is also observed between the four pharmaceutical substances and the occurrence of amenorrhea (haloperidol>risperidone>olanzapine>quetiapine, p<0.0005).The group of females with absence of menses complain mainly for somatic distress deriving from bodily perceptions, obsessive – compulsive manifestations, depressive and anxiety disorders, feelings of anger, phobic anxiety, paranoid mode of thinking. They occupy themselves less with feelings of personal inadequacy and inferiority in comparison with non- amenorrhoeic patients (p<0.0005). Furthermore, menstruation does not bother them and they refuse its influence on their organism despite the fact that they cannot anticipate its onset.Conclusion: The above mentioned results indicate not only scientific importance, since there are no prior similar studies on this topic, but also clinical significance, which means that proper assessment and management of manifestations like hyperprolactinemia, amenorrhea and their implications could enhance the course of the illness and women’s life.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stavroula, Bargiota
- Μπαργιώτα, Σταυρούλα
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35375